-transparent.png){kind=logo}
The effects of prostaglandin E2(PGE2) on the degradation of collagen and non-collagenous peptides in clonal osteoblastic MC3T3-E1 cells were investigated by using highly sensitive assay methods for PZ-peptidase, collagenase-like peptidase (CL-peptidase), dipeptidyl-aminopeptidase (DAP), leucine aminopeptidase (LAP), and post-proline cleaving enzyme (PPCE). PGE2, at concentrations of 0.1 to 4.0 micrograms/ml, doubled the PZ-peptidase and CL-peptidase activities in the cells on 24 h culturing in a dose-dependent manner. PGE2, at a concentration of 2.0 micrograms/ml, enhanced the specific activities of PZ-peptidase, CL-peptidase, DAP, LAP, and PPCE for 75 h after the start of PGE2 stimulation. The time dependent changes in PZ-peptidase and CL-peptidase activities showed similar patterns, and 3- and 2-fold increases were seen after 48 h, respectively. The protein and DNA contents gradually increased after addition of PGE2. Since the PZ-peptidase and CL-peptidase, involved in degradation of collagen peptides, were significantly induced by PGE2 in comparison with LAP and PPCE, involved in the degradation of non-collagenous peptides, these results show that PGE2 specifically stimulates induction of collagen catabolizing enzymes in clonal osteoblasts.
T Chikuma, and
Y Ishii, and
T Kato, and
H Kodama, and
Y Hakeda, and
M Kumegawa
November 1983,
Journal of biochemistry,
T Chikuma, and
Y Ishii, and
T Kato, and
H Kodama, and
Y Hakeda, and
M Kumegawa
January 1983,
The Journal of cell biology,
T Chikuma, and
Y Ishii, and
T Kato, and
H Kodama, and
Y Hakeda, and
M Kumegawa
July 1982,
Journal of cellular physiology,
T Chikuma, and
Y Ishii, and
T Kato, and
H Kodama, and
Y Hakeda, and
M Kumegawa
January 1991,
Journal of cellular physiology,
T Chikuma, and
Y Ishii, and
T Kato, and
H Kodama, and
Y Hakeda, and
M Kumegawa
July 1989,
Journal of biochemistry,
T Chikuma, and
Y Ishii, and
T Kato, and
H Kodama, and
Y Hakeda, and
M Kumegawa
January 1991,
Cellular signalling,
T Chikuma, and
Y Ishii, and
T Kato, and
H Kodama, and
Y Hakeda, and
M Kumegawa
February 1997,
Prostaglandins, leukotrienes, and essential fatty acids,
T Chikuma, and
Y Ishii, and
T Kato, and
H Kodama, and
Y Hakeda, and
M Kumegawa
August 1990,
Calcified tissue international,
T Chikuma, and
Y Ishii, and
T Kato, and
H Kodama, and
Y Hakeda, and
M Kumegawa
October 2000,
Biochemical pharmacology,
T Chikuma, and
Y Ishii, and
T Kato, and
H Kodama, and
Y Hakeda, and
M Kumegawa
July 1994,
Prostaglandins, leukotrienes, and essential fatty acids,
